The presentation concludes that Sorafenib dose escalation to 1200mg or 1600mg/day was achieved in 93% of patients with metastatic RCC.

• 总结索拉非尼剂量提升到1200毫克或者1600毫克每天是可以的对于有肾癌转移的93%25的病人。